296 related articles for article (PubMed ID: 29996478)
1. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.
Lamar JM; Motilal Nehru V; Weinberg G
Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996478
[TBL] [Abstract][Full Text] [Related]
2. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
Elife; 2021 Apr; 10():. PubMed ID: 33913810
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.
Seavey CN; Pobbati AV; Rubin BP
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740643
[TBL] [Abstract][Full Text] [Related]
4.
Seavey CN; Pobbati AV; Hallett A; Ma S; Reynolds JP; Kanai R; Lamar JM; Rubin BP
Genes Dev; 2021 Apr; 35(7-8):512-527. PubMed ID: 33766982
[TBL] [Abstract][Full Text] [Related]
5. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
[TBL] [Abstract][Full Text] [Related]
6. Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma.
Seavey CN; Hallett A; Li S; Che K; Pobbati AV; Ma S; Burtscher A; Kanai R; Lamar JM; Rubin BP
Clin Cancer Res; 2023 Jul; 29(13):2480-2493. PubMed ID: 36598859
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
[TBL] [Abstract][Full Text] [Related]
8. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
10. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription.
Neil E; Paredes R; Pooley O; Rubin B; Kouskoff V
Commun Biol; 2023 Nov; 6(1):1174. PubMed ID: 37980390
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
Doyle LA; Fletcher CD; Hornick JL
Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
Anderson WJ; Fletcher CDM; Hornick JL
Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
[TBL] [Abstract][Full Text] [Related]
14. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
[TBL] [Abstract][Full Text] [Related]
15. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations.
Yamaguchi H; Taouk GM
Front Oncol; 2020; 10():928. PubMed ID: 32596154
[TBL] [Abstract][Full Text] [Related]
16. Current Model Systems for Investigating Epithelioid Haemangioendothelioma.
Neil E; Kouskoff V
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296967
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.
Lee NH; Kim SJ; Hyun J
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808155
[TBL] [Abstract][Full Text] [Related]
18. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma.
Hayashi H; Uemura N; Zhao L; Matsumura K; Sato H; Shiraishi Y; Baba H
Front Oncol; 2021; 11():700315. PubMed ID: 34395269
[TBL] [Abstract][Full Text] [Related]
19. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427
[TBL] [Abstract][Full Text] [Related]
20. Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells.
Lee Y; Finch-Edmondson M; Cognart H; Zhu B; Song H; Low BC; Sudol M
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
